Clinicopathologic variables were evaluated for association with expression of KDM5B (Table 1), the expression levels of KDM5B were robustly correlated with tumor size (P = 0.018), TNM staging (P = 0.023), HbA1C (P = 0.043), and TG (P = 0.035), TC (P = 0.028). This evidence concerns the gene KDM5B and neoplasm.